Key result
Metabolically healthy obesity is linked to ~33% lower all-cause mortality versus non-obese patients.
Why the study?
Distinguishing metabolically healthy obesity from metabolically unhealthy obesity may introduce a nuanced perspective, but their differential impact on outcomes in older patients with cancer-related pulmonary embolism was unclear.
Does metabolically healthy obesity (MHO) or metabolically unhealthy obesity (MUHO) impact all-cause mortality and cardiac arrest in elderly patients with cancer-related pulmonary embolism compared to non-obese patients?
Does metabolically healthy obesity (MHO) or metabolically unhealthy obesity (MUHO) impact all-cause mortality and cardiac arrest in elderly patients with cancer-related pulmonary embolism compared to non-obese patients?
In elderly patients with cancer-related pulmonary embolism, metabolically healthy obesity was associated with a lower risk of in-hospital all-cause mortality compared to non-obese patients, suggesting an obesity paradox.
MHO was associated with lower mortality in elderly cancer-PE; leaves open whether this reflects true protection or confounding.
Background: Although obesity has been widely recognized as a risk factor for cardiovascular morbidity and mortality, distinguishing metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) introduces a nuanced perspective in managing cancer-related pulmonary embolism (PE) among older people. Therefore, this study aims to investigate whether MHO or MUHO phenotypes have a differential impact on in-hospital outcomes. Methods: Using the National Inpatient Sample (NIS) (2016 to 2020) and ICD-10 CM codes, we identified cancer-related PE hospitalizations in elderly (≥65 years) patients. The study evaluated the demographics, comorbidities, and outcomes of cancer-related PE hospitalizations in two groups: patients without obesity and obese patients with MHO and MUHO. The study assessed the adjusted odds of all-cause mortality and cardiac arrest as primary outcomes and healthcare resource utilization as a secondary outcome using multivariable regression analyses. Results: Of 211,070 cancer-related pulmonary embolism (PE) admissions, 87.5% were non-obese, 1.4% were MHO, and 11% were MUHO. MHO patients were primarily female (64.2%), younger (median age 71), and white (85.5%). Medicare was the primary payer, and care was mainly provided in urban teaching hospitals (74%) and the South region (28.9%). MUHO’s prevalence significantly rose from 9.8% in 2016 to 11.9% in 2020 compared to patients with MHO. Patients with MUHO had higher rates of comorbidities compared to other groups. Multivariable regression analysis revealed that patients with metabolically healthy obesity (MHO) demonstrate a significantly lower risk of all-cause mortality (OR: 0.67, 95% confidence interval [CI]: 0.59–0.76) compared to non-obese patients. Conversely, patients with metabolically unhealthy obesity (MUHO) did not have a significant impact on mortality risk (OR: 0.88, 95% CI: 0.67–1.15), all with P < 0.001. Additionally, no significant differences in the rates of cardiac arrest were observed among MHO (OR: 1.14, 95% CI: 0.66–1.98, P = 0.892) or MUHO (OR: 1.01, 95% CI: 0.80–1.26, P = 0.892) patients when compared to non-obese individuals. Notably, patients with MHO experienced prolonged hospital stays (6 days) and incurred higher hospital expenses ($63,228) than other groups. Moreover, patients with MHO exhibited a higher likelihood of being discharged to a skilled nursing facility in comparison with patients with MUHO and those without obesity (28.6% vs 25.6% vs 23.2%). Conclusions: In conclusion, despite the rise in the prevalence of metabolically unhealthy (MUHO) and healthy obesity (MHO), our study focusing on the elderly cohort of cancer patients complicated by PE found a paradoxical effect of obesity on all-cause mortality rates with both metabolically healthy and unhealthy obesity, suggesting a potential protective effect. These findings highlight the need for further research to understand better the mechanisms underlying these associations.
No takes yet. Share an insight, caveat, or question.
Neppala et al. (2025) studied this question. Metabolically healthy obesity (MHO) was associated with a 33% lower risk of all-cause mortality compared to non-obese patients (OR: 0.67), while metabolically unhealthy obesity had no significant impa.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: